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On-cell catalysis by surface engineering of live cells
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Metal-catalyzed chemical transformations performed at the cellular level bear great potential
for the manipulation of biological processes. The complexity of the cell renders the use of
transition metal chemistry difﬁcult in cellular systems. The delivery of the reactive catalyst
and the control of its spatial localization remain challenging. Here we report the surface
functionalization of the unicellular eukaryote Chlamydomonas reinhardtii with a tailor-made
artiﬁcial metalloenzyme for on-cell catalysis. The functionalized cells remain viable and are
able to uncage a ﬂuorogenic substrate on their surface. This work leverages cell surface
engineering to provide live cells with new-to-nature reactivity. In addition, this operationally
simple approach is not genetically encoded and thereby transient, which offers advantages
with regard to temporal control, cell viability, and safety. Therefore, and as a feature, the
movement of the functionalized cells can be directed by light (via phototaxis), allowing for
the three-dimensional localization of catalysts by outside stimuli.
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Over the past decades, the ability to introduce new-to-nature chemical reactions in living cells has emerged as adesirable goal, and as requirement, much progress has
been achieved in the ﬁeld of bioorthogonal chemistry1. The
development of chemospeciﬁc biocompatible reactions enabled the
labeling of biomolecules and the activation of probes at a cellular
level, key to the study of biological processes. However, until
recently, the set of available bioorthogonal transformations was
mostly limited to bond-forming reactions for bioconjugations2–10.
Technologies to perform chemical synthesis beyond ligations at a
cellular level are still needed. Bond-breaking reactions bear a great
potential in chemical biology and medical applications11. Despite
constant progress in this ﬁeld, the selective cleavage of chemical
bonds without perturbing cells’ native chemical processes still
remains a challenge. The introduction of transition metal com-
plexes into cells has recently proven to be able to bring new
reactivity to cellular systems and was efﬁciently used for the acti-
vation of probes and prodrugs in cellulo12–28. However, most
metal complexes penetrate cells with poor site selectivity leading to
potential undesired side-reactions. The lack of spatial control as
well as control over the faith of the reactive metal center in the cell
constitute a barrier to further medical applications.
For years, evolution has shaped and optimized enzymes,
making possible a set of reactions crucial to life. On the other hand,
chemists have developed numerous methods for the synthesis of
molecules beneﬁcial to mankind. Previous work showed that both
of these worlds can be merged to complement the work of natural
enzymes. Artiﬁcial metalloenzymes (ArMs hereafter), resulting
from the incorporation of a reactive metal cofactor into a protein
scaffold, combine the versatility of metal catalysts with the unique
tri-dimensional environment of proteins. From oleﬁn metathesis29
and cyclopropanation30 to C-H insertion31, recent advances in
protein engineering and organometallic synthesis enabled a wide
range of non-natural reactions to be performed in a biocompatible
manner32. The artiﬁcial allylic deallylase used here, catalyzes the
cleavage of allyl-carbamate protected amines. Examples of this
versatile reaction taking place on E. coli and in mammalian cells
have been recently reported33,34.
The cell surface is the site of numerous key biological pro-
cesses. For this reason, the engineering of the surface of mam-
malian cells, bacteria, yeasts, and microalgae has gained
increasing attention. Synthetic molecules bearing deﬁned func-
tional groups are currently exploited to remodel cell surfaces in a
selective and rational manner.35 The modiﬁcation of cell phe-
notypes by chemical surface engineering found applications in
many areas including gene transfer36, proteomics37, cell ther-
apy38, cell patterning39, or nucleic acid transfection40.
Surface functionalization of live cells with an artiﬁcial metal-
loenzyme could allow both reactivity and spatial control over the
desired transformation. In this context, bacterial surface display
has emerged as a promising technology for the development and
the study of new reactions at a cellular level34,41. We reasoned
that the functionalization of the cell surface of an eukaryote
without relying on genetic means would represent an attractive
alternative. Such approach might offer ﬂexibility by allowing time
control of the functionalization, being non-hereditary and oper-
ationally simple to perform.
In this study, we report the surface functionalization of live
Chlamydomonas reinhardtii cells with a tailor-made artiﬁcial allylic
deallylase for on-cell catalysis. The engineered cells are viable and
possess the ability to catalyze a reaction that is new-to-nature.
Results
Cell surface functionalization of Chlamydomonas reinhardtii.
For our proof of concept of on-cell catalysis, we selected the
unicellular green alga Chlamydomonas reinhardtii (C. reinhard-
tii). The microalga, for which the full genome sequence has been
obtained42, is widely used as model organism in cell and mole-
cular biology43. The microscopic eukaryote has gained attention
due to its ability to carry out photosynthesis. Its use has recently
expanded from the study of fundamental processes to applied
research in biofuels44, therapeutic protein production45, or
wound healing46,47. Interested in leveraging further the potential
of C. reinhardtii, our group recently reported its surface engi-
neering for antibiotic delivery48. C. reinhardtii cells are spherical,
10 µm large, and feature two ﬂagella which allow motility.
Combined with its ability to sense light, locomotion renders the
microalga phototactic49. The cell membrane of C. reinhardtii is
surrounded by a multilayered cell wall composed of glycopro-
teins. Both covalent and non-covalent interactions between gly-
copeptide residues give rise to the cell wall structure50.
We envisioned to install the artiﬁcial metalloenzyme on the cell
surface of C. reinhardtii by a covalent approach. Several types of
chemical functionalizations have recently been reported. These
techniques take advantage of reactive functional groups readily
available at the cell surface, such as thiols or amines38,39,51,52. In
our case, we hypothesized that amino acid residues bearing amino
groups within the cell wall of C. reinhardtii might react with good
electrophiles such as N-hydroxysuccinimide esters. To test this
hypothesis, we ﬁrst aimed at functionalizing the cell surface with
succinimidyl ester 1. Cells were collected from the culture,
washed from the culture medium, resuspended in phosphate-
buffered saline (PBS), and incubated with carboxyﬂuorescein
succinimidyl ester 1 for 1 h (Fig. 1a). After washing and
resuspension in PBS, cells were analyzed by confocal laser
scanning microscopy. As illustrated in Fig. 1b, ﬂuorescence
images revealed that 1 covalently reacts with C. reinhardtii as
witnessed on the green channel (detection of ﬂuorescein).
Moreover, we were pleased to observe that the labeling was
restricted to the cell surface as no ﬂuorescence signal was detected
from the cytoplasm. To conﬁrm that the covalent labeling was
indeed targeting the cell wall, we repeated the experiment with C.
reinhardtii CC-406, a cell wall-deﬁcient mutant which lacks
major components of the cell wall. In the absence of a proper cell
wall, only a faint labeling was detected (Supplementary Figure 1),
conﬁrming that the N-hydroxysuccinimide ester moiety is
reacting with glycoprotein components of the cell wall of C.
reinhardtii.
Functionalization of C. reinhardtii with streptavidin. Encour-
aged by these results, we next employed the N-hydro-
xysuccinimide (NHS) ester strategy for C. reinhardtii
functionalization with streptavidin (SAV), the host protein of our
artiﬁcial metalloenzyme. The high afﬁnity between the tetrameric
protein isolated from Streptomyces avidinii and its ligand biotin is
extensively used in the molecular life sciences. The tetrameric
structure of streptavidin allows it to bind simultaneously to
multiple biotinylated ligands. We envisioned to functionalize the
cell surface with biotin anchor 2 in a ﬁrst step (Fig. 2a). The NHS
group would allow for covalent reaction with C. reinhardtii as
demonstrated previously. The polyethylene glycol chain would
act as a spacer and increase the water solubility of the anchor. The
biotin moiety would provide the afﬁnity to streptavidin and
would allow us to install the desired protein on the cell surface.
Cells were ﬁrst washed with PBS, and incubated for 1 h with
biotin anchor 2 (Fig. 2a). After washing the excess of anchor 2,
cells were resuspended in PBS, incubated with streptavidin-Alexa
Fluor 488 conjugate 3 for 20 min, washed, and imaged on a
confocal laser scanning microscope. Different concentrations
were screened for 3 (Supplementary Figure 2). As presented in
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Fig. 2b, a clear signal from the cell surface in the Alexa 488
channel could be detected, conﬁrming functionalization with
streptavidin. Once again, no signal was detected from cells’
cytoplasm, highlighting great cell wall selectivity. Control sam-
ples, consisting of cells incubated with streptavidin-Alexa 488
without prior functionalization with the biotin anchor 2, dis-
played no signal on the Alexa 488 channel. The absence of signal
in these control samples conﬁrmed that there is no unspeciﬁc
binding of streptavidin to the microalga and that prior functio-
nalization with biotin anchor 2 is a prerequisite. To further
demonstrate that the functionalization is statistically signiﬁcant,
ﬂow cytometry experiments were carried out. As displayed in
Fig. 2c, previous results from confocal microscopy imaging were
conﬁrmed. Functionalization with streptavidin is statistically
signiﬁcant, and more than 99% of the treated cells displayed
green ﬂuorescence with a relatively narrow distribution of the
ﬂuorescence intensity (Supplementary Figures 3 and 4). More-
over, only cells treated with both anchor 2 and streptavidin-Alexa
488 conjugate 3 displayed green ﬂuorescence, as depicted in
Fig. 2d. These experiments further conﬁrmed that the biotin
anchor 2 is necessary for the functionalization with streptavidin,
excluding non-speciﬁc interactions of streptavidin with C. rein-
hardtii. We then focused on assessing the viability of the func-
tionalized cells. Propidium iodide, a red-ﬂuorescent nuclear stain,
was used to selectively stain non-viable cells. As illustrated in
Fig. 2e, we were pleased to see that the functionalization with
both the biotin anchor 2 (step 1) and streptavidin (step 2) had
very small impact on the cell viability since the median ﬂuores-
cence intensity of propidium iodide was very similar for all
samples. A total of 77% of the treated cell population was func-
tionalized and viable. The procedure described above thus allows
for speciﬁc surface functionalization of C. reinhardtii with
streptavidin, with preserved cell viability.
Development of an artiﬁcial allylic deallylase. After demon-
strating the functionalization of live cells with the streptavidin
host, focus was set on the reaction and the artiﬁcial metalloen-
zyme. We selected the cleavage of allyl-carbamate-protected
amines, a reaction that is foreign to nature, as our target trans-
formation. Amines are a versatile functional group present in a
broad range of natural products as well as synthetic drugs. The
deprotection of amino groups within active small molecules and
biomolecules can be used for prodrug activation (Fig. 3a). Caging
of a functional group in a molecule of interest can be used to
lower its activity by masking an important moiety in the parent
molecule. Once the caging group is cleaved off, the molecule
regains its inherent biological activity. If prodrugs have been
successfully used to enhance a drug’s permeability, distribution,
or metabolism, the major challenge remains the usage of pro-
drugs to overcome toxicity issues.53 In particular, prodrugs
might be a solution to lower adverse effects on healthy tissues
in treatments relying on highly cytotoxic but poorly
selective agents.54 In this particular case, a catalytic and
spatial control of this uncaging process is crucial for therapeutic
applications. As a model reaction for on-cell catalysis, we selected
the uncaging of allyl-carbamate-protected aminocoumarin 4 by
the organoruthenium complex 5, reported by Meggers and co-
workers19 (Fig. 3b). The authors reported that ruthenium-based
catalysts such as 5 could perform the catalytic cleavage of O-allyl
carbamates in biologically relevant conditions. ProCoumarin 4 is
water soluble and the parent free aminocoumarin 6 displays an
increased ﬂuorescence upon uncaging, allowing for straightfor-
ward monitoring of the reaction.
We thus synthesized biotinylated ligand 8 and reacted it with
complex 7 to form the biotinylated ruthenium catalyst [CpRu
(QA-Biot)(OH2)] 9 (QA= 2-quinolinecarboxylate). Incorpora-
tion into streptavidin afforded the artiﬁcial allylic deallylase
(ADAse) 10 (Fig. 3c). In the deprotection of proCoumarin 4, the
free ruthenium cofactor 9 revealed only modest activity.
However, incorporated into streptavidin wild type (SAV WT)
the yield of product 6 was increased threefold (Fig. 3d). We
performed an in vitro mutant screening at positions S112X and
K121X in close proximity of the active metal cofactor
(Supplementary Figures 5 and 6). Overall, 34 single mutants
were tested for ADAse activity. The best performing mutants at
the positions S112X and K121X were S112M and K121R,
respectively. We subsequently screened a selected set of double
mutants: unfortunately, the double mutant S112M-K121R did not
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Fig. 1 Succinimidyl esters enable covalent labeling of the cell wall of C.
reinhardtii. a Schematic representation of cell wall covalent labeling with 1. b
Confocal laser scanning microscopy images of cells after treatment with
PBS (control) or with 1 (0.65 mM), 1 h, PBS (treated). Green channel:
detection of ﬂuorescein. Red channel: detection of the chloroplast. Scale
bar, 10 µm
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Fig. 2 Surface functionalization of C. reinhardtii with streptavidin. a Schematic representation of the two-step procedure for surface immobilization of
streptavidin. In a ﬁrst step, cells are covalently functionalized with the biotin anchor 2 and then incubated with the streptavidin-Alexa 488 conjugate 3. b
Confocal laser scanning microscopy images of cells after treatment with PBS (not treated), 3 (50 µg mL−1), 20min, PBS (control) or 2 (0.65 mM), 1 h, PBS
then 3 (50 µg mL−1), 20min, PBS (treated). Green channel: detection of Alexa 488. Red channel: detection of the chloroplast. Images are shown as red and
green channel overlay. Scale bar, 10 µm. c Flow cytometry analysis after functionalization. Representation of one experiment of n= 3 as a density plot,
propidium iodide (Texas red channel) vs. Alexa 488 (FITC channel). d Efﬁciency of the functionalization with streptavidin-Alexa 488 conjugate: median
Alexa 488 ﬂuorescence intensity. e Cell viability after functionalization with streptavidin: median propidium iodide ﬂuorescence intensity. d, e Data are
represented as mean ± SD (n= 3) and analyzed by one-way ANOVA (post hoc Tukey test; *P≤ 0.05; **P≤ 0.01; ***P≤ 0.001; ****P≤ 0.0001)
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reveal a higher activity than the corresponding single mutant
K121R (48% and 55% yield, respectively). However, the
combination of mutant S112Y, which only displayed the fourth
highest activity in the single mutant screening, with mutant
K121R resulted in a highly active ADAse. Catalysis with the
double mutant S112Y-K121R yielded a seven-fold higher
concentration of coumarin product 6 than the corresponding
wild-type ADAse (81% vs. 11% yield) after 4 h at RT.
Cell surface engineering with the ADAse. After achieving a good
catalytic activity with the ADAse [CpRu(QA-Biot)(OH2)] · SAV
S112Y-K121R, the focus was set on developing a procedure for its
immobilization on the microalga. We planned to adapt the pro-
cedure described above for the cell surface functionalization with
streptavidin (Fig. 4a). Cells were ﬁrst washed in PBS, treated with
the biotin anchor 2 (0.65mM), and washed again. To ensure the
availability of free SAV-binding sites, necessary for the surface
functionalization, a 4:1 ratio of free SAV-binding site:cofactor was
used (vs. a 2:1 ratio for the in vitro screening). In parallel, the Ru-
cofactor 9 (2.5 µM) was prepared by incubating the biotinylated
ligand 8 with 7 in a 1:1 ratio in DMF for 15min and then incu-
bated with the selected streptavidin S112Y-K121R mutant (10 µM
free biotin-binding sites) to assemble the ADAse 10. Biotinylated
cells were then incubated with 10 for 20min, the buffer was
removed, the cells were washed and resuspended in PBS (Fig. 4b).
After the functionalization of C. reinhardtii with the ADAse, we
were concerned about cell viability, as transition metals are known
to be cytotoxic above certain concentrations. The cell viability was
thus assessed by ﬂow cytometry after functionalization, and the
immobilization of ADAse 10 turned out to have no detectable
impact on cells’ viability (Supplementary Figures 8 and 9).
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Activity of the engineered cells. With the functionalized and
viable cells in hand, we then moved on to test their ability to
perform the desired transformation. The reaction was initiated by
addition of proCoumarin 4 at a concentration of 400 μM in PBS
to the engineered cells. After 18 h, ﬂuorescence of the uncaged
coumarin 6 was measured (Fig. 4c). Reactivity could be unam-
biguously detected for cells functionalized with the selected
ADAse 10. Untreated cells did not show any intrinsic catalytic
activity. Cells incubated with Ru-cofactor 9 or the ADAse 10
without prior incubation with biotin anchor 2 were not active
either. Demonstrating the effect of ligand-accelerated catalysis,
cells functionalized with the WT ADAse showed a greatly
reduced reactivity compared to the selected mutant, corroborat-
ing the results of the streptavidin mutants screening. These
experiments conﬁrmed: (i) that there is no C. reinhardtii-derived
background activity; (ii) that there is no cellular uptake of the
Ru-cofactor 9 nor the ADAse 10; (iii) that biotin anchor 2 is
needed; (iv) that the assembly of the streptavidin and the cofactor
9 is responsible for the observed transformation.
We next studied the inﬂuence of the biotin anchor 2
concentration on the reactivity. Cells were treated with 2 at three
different concentrations (0.65, 1.6, and 3.2 mM), maintaining the
concentration of Ru-cofactor 9 and the streptavidin host S112Y-
K121R constant to 2.5 and 10 µM, respectively. As illustrated in
Fig. 4d, increased biotin anchor concentration led to higher
activity and the uncaging of proCoumarin 4 was limited to cells
engineered with the ADAse, albeit in low yields (3 to 4%). One
can indeed imagine that an increased incubation concentration of
2 leads to denser biotinylation of the cell surface, and thus to a
greater amount of ADAse 10 on the cell surface. Since the Ru-
cofactor 9 and the streptavidin host concentrations were
maintained constant, these results also indicate that after
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incubation with biotin anchor 2 at 0.65 mM, cells take up less
than 2.5 µM of the ADAse 10. These experiments also reveal that
a ﬁve-fold increase in concentration of the biotin anchor 2 does
not lead to a ﬁve-fold increase in activity. This suggests that, as
expected, a limited amount of ADAse 10 can be installed on the
cell surface.
After demonstrating the catalytic activity of the engineered
cells, focus was set on preserving the cell viability. Because the
previous reaction conditions resulted in a decreased number of
viable cells after catalysis, efforts were directed towards identify-
ing reaction conditions with a reduced impact on cell viability.
We hypothesized that prolonged exposure to PBS instead of C.
reinhardtii culture medium (Kuhl medium) could be a reason for
the decreased cell viability after catalysis. Additional investiga-
tions on the reaction time and reaction medium revealed that PBS
has indeed a negative inﬂuence on cell viability (Supplementary
Figure 10). Under optimized conditions (15 h reaction time in
Kuhl medium), we were pleased to see that the engineered cells
could signiﬁcantly uncage the proCoumarin 4 (Fig. 5a) with a
preserved cell viability albeit with lower efﬁciency (Fig. 5b and
Supplementary Figure 11).
To further evaluate the impact of the functionalization on the
cell viability, we challenged the phototactic ability of the cells after
functionalization. C. reinhardtii CC-124, a strain with negative
phototaxis ability55 (capacity to move away from the light source)
was functionalized with the ADAse as previously described and
subjected to a phototaxis assay. The functionalized cells still
displayed negative phototaxis after functionalization (Fig. 6) as
cells moved away from the green LED over the course of 15 min
in a Petri dish. However, as the phototatic ability of C. reinhardtii
depends on a variety of parameters (intensity of the light source,
medium, growth phase), consistent movement was difﬁcult to
obtain.
Discussion
In summary, we have developed a system to endow a cell with the
ability to catalyze on its surface a transformation that is new-to-
nature. The approach developed here does not rely on the bio-
logical machinery of the target cell but takes advantage of che-
mical surface functionalization to introduce the artiﬁcial
metalloenzyme. To the best of our knowledge, this study repre-
sents the ﬁrst example of chemical surface engineering of a
eukaryotic cell with a tailor-made artiﬁcial metalloenzyme. The
artiﬁcial allylic deallylase introduced on the cell surface functions
as a “chemical prosthesis” that provides the cell with new che-
mical capabilities. The streptavidin possesses a dual function and
allows for both shielding of the metal center from the biological
environment and cell surface immobilization of the metalloen-
zyme. The approach described here seems complementary to the
strategy relying on the transformation of native membrane
receptors into metalloenzymes, recently reported by Ghattas
et al.56. However, introducing a fully artiﬁcial metalloenzyme
based on the biotin-streptavidin technology has the advantage of
providing more versatility (a single host protein for a variety of
biotinylated cofactors) and the possibility to optimize the host
protein by mutagenesis. Implementing new chemistry in cellular
systems from the outside can be beneﬁcial. It gives the advantage
of closely controlling the site of the introduced abiotic reactive
center and thus the site of the reaction to be catalyzed. This could
open the door to spatial control over the process of prodrug
uncaging that may prove beneﬁcial for medical applications. The
principle developed here could be expanded to surface engi-
neering of mammalian cells. In the context of immunotherapy
and cell therapy, the cell surface plays a crucial role, and the
important efforts made in synthetic biology could beneﬁt from
new reactivity being implemented on the cell membrane. As an
example, with the use of selective surface engineering methods
(i.e. metabolic glycoengineering) to introduce the biotin moiety,
one could develop further the approach discussed here to selec-
tively equip cancer cells with such chemical prosthesis. The target
cells would then be equipped to uncage prodrugs in an ortho-
gonal and selective fashion on their surface. Giving the potential
applicability of the concept introduced here, our aim is to expand
this approach in order to provide new chemistry to modulate
cellular systems from the outside-in.
Methods
General. 5(6)-Carboxyﬂuorescein N-hydroxysuccinimide ester, Phosphate-
Buffered Saline (Gibco, pH 7.4, 1 × ) and Prolong® Diamon Antifade Mountant
were purchased from Thermo Fisher Scientiﬁc. Tris(acetonitrile)cyclopentadie-
nylruthenium(II) hexaﬂuorophosphate and propidium iodide were purchased from
Sigma Aldrich. NHS-PEG12-biotin was purchased from BroadPharm. Dimethyl-
formamide was purchased form Acros Organics. Streptavidin-Alexa Fluor 488
B C D E
0
400
800
1200
1600
Co
um
ar
in
flu
or
es
ce
nc
e 
in
te
ns
ity
Cells
proCoumarin 4
SAV S112Y-K121R
Cofactor 9
Biotin anchor 2
+
+
–
–
–
+
+
+
+
–
+
+
+
+
+
+
+
+
+
****
****
****
A B C D E
0
50
100
150
200
250
Pr
op
id
iu
m
 io
di
de
m
e
di
an
 fl
uo
re
sc
en
ce
 in
te
ns
ity
+
–
–
–
–
+
+
–
–
–
+
+
+
+
–
+
+
+
+
+
+
+
WT(1)
+
+
n.s. n.s.
n.s. n.s.
Cells
proCoumarin 4
SAV S112Y-K121R
Cofactor 9
Biotin anchor 2
WT(1)
a
b
Fig. 5 On-cell catalysis with preserved cell viability. Functionalization
conditions: 2 (0.65mM), 1 h, PBS; cofactor 9 (2.5 µM), streptavidin S112Y-
K121R (10 µM free biotin-binding sites). a Uncaging of the proCoumarin 4
(400 µM, Kuhl medium) by the functionalized cells. Activity is given as
ﬂuorescence intensity coming from 6 in arbitrary units after 15 h at 25 °C.
b Cell viability after reaction determined by ﬂow cytometry with propidium
iodide. a, b Data are represented as mean ± SD (n= 3) and analyzed by
one-way ANOVA (post hoc Tukey test; *P≤ 0.05; **P≤ 0.01; ***P≤ 0.001;
****P≤ 0.0001). (1) Wild-type streptavidin was used in this case
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conjugate was purchased from Invitrogen. Cell counting slides were purchased
from Kova International. All reagents were used without further puriﬁcation. PBS
buffer and Kuhl medium were strained over a Filtropur BT 50 0.45 mm ﬁlter
(Sarstedt) prior to use.
Cell culture. Chlamydomonas reinhardtii (11–32b) was purchased from EPSAG
(Experimentelle Phykologie und Sammlung von Algenkulturen der Universität
Göttingen) and grown in Kuhl medium (1011.1 mg L−1 KNO3, 621 mg L−1
NaH2PO4·H2O, 89 mg L−1 Na2HPO4·2H2O, 246.5 mg L−1 MgSO4·7H2O, 14.7 mg
L−1 CaCl2·2H2O, 6.95 mg L−1 FeSO4·7 H2O (Fe-EDTA complex), 1 mL L−1
micronutrient solution (61.0 mg L−1 H3BO3, 169.0 mg L−1 MnSO4·H2O, 287.0 mg
L−1 ZnSO4·7H2O, 2.5 mg L−1 CuSO4·5H2O, 12.5 mg L−1 (NH4)6Mo7O24·4H2O)
for 1 L of medium) at 20 °C under cycles of medium light (30 V) for 12 h and dark
for 12 h. The cell wall-deﬁcient mutant (CC-406 cw15 mt-) was purchased from the
Chlamydomonas Resource Center, University of Minnesota and grown in Tris
Minimal medium (2.42 mg L−1 Triz-ma® base, 25 mL salt solution (15.0 mg L−1
NH4Cl, 4 g L−1 MgSO4·7H2O, 2.0 g L−1 CaCl2·2H2O), 0.375 mL phosphate solu-
tion (28.8 g L−1 K2HPO4, 14.4 g L−1 KH2PO4), 1 mL Fe-EDTA complex
(6.95 mg L−1 FeSO4·7H2O)) at 20 °C under cycles of medium light (30 V) for 12 h
and dark for 12 h. Chlamydomonas reinhardtii CC-124 was purchased from the
Chlamydomonas Resource Center, University of Minnesota and grown in TAP
medium (20 mL of 1M Tris base, 1 mL of glacial acetic acid, 10 mL of solution A
(40.0 g L−1 NH4Cl, 50 g L−1 CaCl2·2H2O, 10 g L−1 MgSO4·7H2O), 1.0 mL phos-
phate solution (108 g L−1 K2HPO4, 56 g L−1 KH2PO4), 10 mL Tris-acetate solution
(242 g L−1 Tris base, 100 mL L−1 glacial acetic acid), 1 mL Hutner’s trace elements
solution (50.0 g L−1 EDTA-Na2, 11.14 g L−1 H3BO3, 22.0 g L−1 ZnSO4·7H2O, 5.1 g
L−1 MnCl2, 5.0 g L−1 FeSO4, 1.6 g L−1 CoCl2, 1.6 g L−1 CuSO4·5H2O, 1.1 g L−1
(NH4)6Mo7O24·4H2O)) for 1 L of medium, at 20 °C under cycles of medium light
(30 V) for 12 h and dark for 12 h.
Labeling of C. reinhardtii with 5(6)-carboxyﬂuorescein. Microalgae samples
were taken from the culture and transferred in Eppendorf tubes. The cell density
was determined with a counting grid and adjusted to 3 × 106 cells mL−1. The
samples were then centrifuged at 700 RCF for 5 min to afford the algae pellet. The
supernatant (950 μL) was removed and PBS (950 μL) was added. Samples were
vortexed, centrifuged at 700 RCF for 5 min, the supernatant (950 μL) was removed,
and replaced by fresh PBS (950 μL). This washing procedure was repeated three
times. For the last repetition, PBS (950 μL) was removed, the freshly prepared
solution of 5(6)-Carboxyﬂuorescein N-hydroxysuccinimide (0.65 mM in PBS) was
added and samples were vortexed. The samples were then incubated in a ther-
moshaker at 360 rpm for 40 min and at 700 rpm for 20 min at 25 °C. After incu-
bation, samples were washed according to the following procedure: samples were
ﬁrst centrifuged at 700 RCF for 5 min. The supernatant (950 μL) was removed and
replaced with fresh PBS (950 μL). Samples were vortexed and centrifuged again.
This washing procedure was repeated six times.
Functionalization of C. reinhardtii with streptavidin. Microalgae samples were
taken from the culture, strained, and transferred in Eppendorf tubes. The cell
density was determined with a counting grid and adjusted to 1 × 106 cellsmL−1.
The samples were then centrifuged at 700 RCF for 5 min to afford the algae pellet.
The supernatant (950 µL) was removed and PBS (950 µL) was added. Samples were
vortexed, centrifuged at 700 RCF for 5 min, the supernatant (950 µL) was removed
and replaced by fresh PBS (950 µL). This washing procedure was repeated three
times. For the last repetition, PBS (950 µL) was removed, the freshly prepared
solution of biotin anchor 2 (0.65 mM in PBS) was added, and samples were vor-
texed. The samples were incubated in a thermoshaker at 360 rpm for 40 min and at
700 rpm for 20 min at 25 °C. After incubation, samples were washed according to
the following procedure. Samples were ﬁrst centrifuged at 700 RCF for 5 min. The
supernatant (950 µL) was removed and replaced with fresh PBS (950 µL). Samples
were vortexed and centrifuged again. This washing procedure was repeated six
times. A freshly prepared solution of streptavidin-Alexa Fluor 488 conjugate (50 µg
mL−1 in PBS) was added, the samples were vortexed, and then shaken in a ther-
moshaker at 360 rpm and 25 °C for 20 min. After incubation, samples were washed
three times according to the procedure described above.
Microscopy imaging. Coverslips were coated with a 0.1% gelatin solution for
15 min and air dried. On drop of algae suspension was applied on the coverslip and
the water was evaporated without the cells being dried out. A ﬁxation solution (9%
formaldehyde, 3% glutaraldehyde, 0.1% NaCl) was mixed 1:1 with Kuhl medium,
placed on the cells, and left for 5 min at room temperature. The ﬁxation solution
was rinsed away with Kuhl medium and the sample was mounted with Prolong®
Diamon Antifade Mountant. A Leica SP5 was used with the following parameters:
argon laser, 20%; resolution, 8 bits; room temperature; objective, HC PL APO
lambda blue 63.0 × 1.40 OIL UV; Leica AF acquisition software. For details on laser
and gain see Supplementary Table 1.
Microscopy processing. Images were processed using Fiji (ImageJ) software by
adjusting the brightness and contrast. All acquired images are 8-bit images with a
full display range of 0–255. Overlay images have not been corrected after merging
the channels. For details see Supplementary Table 2.
Instrument parameters for ﬂow cytometry. For the detection of chlorophyll, a
488 nm laser was used with 695/40 emission ﬁlters. For the detection of Alexa Fluor
488, a 488 nm laser was used with 530/30 emission ﬁlters. For the detection of
propidium iodide, a 561 nm laser was used with 610/20 emission ﬁlters.
Flow cytometry analysis of functionalization efﬁciency. Samples were cen-
trifuged for 5 min at 2000 RCF. The supernatant was removed and replaced by
fresh Kuhl Medium. A volume corresponding to two million cells (based on pre-
vious cell density measures) was placed to 5 mL tubes and the volume completed to
a total volume of 600 μL with Kuhl medium and kept in the dark. The resulting cell
suspensions were then analyzed on a BD LSR Fortessa SORP (BD Biosciences). A
488 nm laser was used for the excitation of Alexa Fluor 488 and a FITC (530/30)
ﬁlter for the detection of the emitted ﬂuorescence signal (peak area).
Flow cytometry analysis of cell viability. Samples were centrifuged for 5 min at
2000 RCF. The supernatant was removed and replaced by fresh Kuhl Medium. A
volume corresponding to two million cells (based on previous cell density mea-
sures) was placed to 5 mL tubes and the volume completed to a total volume of
600 μL with Kuhl medium. Dead cells for positive control were heated to 90 °C for
20 min. Propidium iodide (2.5 mM in DMSO, 1.8 μL) was added, and the sample
was vortexed. The resulting cell suspensions was then analyzed on a BD LSR
a
b
Fig. 6 Cells functionalized with the ADAse 10 maintain a phototactic
response. C. reinhardtii CC-124 was functionalized as previously described
and transferred to a Petri dish. a Picture taken before illumination with a
green LED. b Picture taken after illumination with a green LED from one side
of the dish for 15min. Scale bar, 1 cm
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Fortessa SORP (BD Biosciences). A 561 nm laser was used for the excitation of
propidium iodide and a PE-Texas Red (610/20) ﬁlter for the detection of the
emitted ﬂuorescence signal (peak area).
Processing of ﬂow cytometry data. All ﬂow cytometry data recorded as described
above were processed with FlowJo.
Synthesis of the ruthenium cofactor 9. Ruthenium cofactor 9 was prepared
in situ by mixing solutions of [CpRu(MeCN)3]PF6 7 and biotinylated ligand 8 in a
1:1 ratio in DMF. Ligand 8 was prepared as described by Heinisch et al.34. Pro-
Coumarin 4 and product 6 were prepared as described by Meggers et al.19.
Expression of streptavidin isoforms. Streptavidin isoforms were expressed in
E. coli BL21(DE3) cells containing pET11b_SAV plasmids and puriﬁed as descri-
bed elsewhere57. The number of free biotin-binding sites was determined by
titration with biotin-4-ﬂuorescein58.
Uncaging of proCoumarin 4 with the ADAse. The following stock solutions were
prepared: (i) PBS (1×, pH 7.4) containing 50mM Na2HPO4/NaH2PO4 and 0.9%
NaCl, (ii) streptavidin isoforms (2mM free biotin-binding sites in water), (iii)
ruthenium cofactor 9 (1mM; prepared by mixing 2mM solutions of [CpRu(MeCN)3]
PF6 7 and biotinylated ligand 8 in DMF in a 1:1 ratio), and (iv) coumarin substrate 4
(10 mM in water). Catalysis reactions were performed in ﬂat 96-well plates at a
reaction volume of 200 μL and a substrate concentration of 500 μM. PBS buffer was
ﬁlled into a 96-well plate followed by the addition of streptavidin and ruthenium
cofactor stock solutions. The resulting solution was incubated at room temperature
for 10min (to allow streptavidin to bind to the biotinylated cofactor). Substrate stock
solution was added and the plate was sealed with an aluminum cover and incubated
under the given conditions. An aliquot of the reaction mixture (3 μL) was then diluted
with water (147 μL) in a new ﬂat black 96-well plate. Fluorescence of the product 6
was determined in a plate reader at λex.= 395 nm/λem.= 460 nm and compared with
a standard curve of the product (Supplementary Figure 6).
Functionalization of C. reinhardtii with the ADAse. Microalgae samples were
taken from the culture, strained, and transferred in Eppendorf tubes. The cell
density was determined with a counting grid and adjusted to 4 × 106 cells mL−1.
The samples were then centrifuged at 2000 RCF for 5 min to afford the algae pellet.
The supernatant (950 µL) was removed and PBS (950 µL) was added. Samples were
vortexed, centrifuged at 2000 RCF for 5 min, the supernatant (950 µL) was
removed and replaced by fresh PBS (950 µL). This washing procedure was repeated
three times. For the last repetition, PBS (950 µL) was removed, the freshly prepared
solution of biotin anchor 2 (0.65 mM in PBS) was added, and samples were vor-
texed. The samples were incubated in a thermoshaker at 360 rpm for 40 min and at
700 rpm for 20 min at 25 °C. A stock solution of the ruthenium cofactor 9 was
prepared by incubating tris(acetonitrile)cyclopentadienylruthenium(II)hexa-
ﬂuorophosphate 7 (1 mM in DMF) and the biotinylated ligand 8 (1 mM in DMF)
in a 1:1 ratio for 15 min. The artiﬁcial metalloenzyme was then assembled by
incubating streptavidin (10 µM, free biotin-binding sites) with the ruthenium
cofactor (2.5 µM) in PBS in a total volume of 180 µL for 15 min. This solution was
then transferred to the cells in a total volume of 250 μL. Samples were shaken on a
thermoshaker at 350 rpm and 25 °C for 20 min. After incubation, samples were
washed according to the following procedure. Samples were ﬁrst centrifuged at
2000 RCF for 5 min. The supernatant (250 μL) was removed and replaced with
fresh PBS (950 μL). Samples were vortexed and centrifuged again. This washing
procedure was repeated three times.
Optimized on-cell uncaging of the proCoumarin 4. Cells were ﬁrst functiona-
lized with the artiﬁcial allylic deallylase and washed as described above. ProCou-
marin 4 (400 µM in Kuhl medium, 200 µL total volume) was added to the
microalgae pellet. The samples were then incubated in the dark on a thermoshaker
at 950 rpm and 25 °C for 15 h. Samples were then centrifuged at 2000 RCF for
5 min. The reaction supernatant was removed and ﬁltered through a PTFE 0.2 μm
syringe ﬁlter. The ﬁltered reaction supernatant (30 μL) and PBS buffer (120 μL)
were placed in a 96-well plate and analyzed on a plate reader (λex.= 395 nm, λem.
= 460 nm).
Statistical analyses. Prism 7 was used for data analysis and representation. Sta-
tistical analysis was performed by one-way analysis of variance (ANOVA) with
post hoc Tukey test (for multiple comparison) and P-values <0.05 were considered
statistically signiﬁcant. The results were deemed signiﬁcant at 0.01 < *P ≤ 0.05, very
signiﬁcant at 0.001 < **P ≤ 0.01, extremely signiﬁcant at 0.0001 < ***P ≤ 0.001 and
extremely signiﬁcant at ****P ≤ 0.0001.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available
either in the paper and in the Supplementary Information or from the authors
upon reasonable request.
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